Stem Cell Banking Market Research Report by Service (Analysis, Collection, and Processing), Source, Type, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

Stem Cell Banking Market Research Report by Service (Analysis, Collection, and Processing), Source, Type, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Stem Cell Banking Market size was estimated at USD 10.69 billion in 2021 and expected to reach USD 12.46 billion in 2022, and is projected to grow at a CAGR 16.80% to reach USD 27.16 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Stem Cell Banking to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Service, the market was studied across Analysis, Collection, Processing, Storage, and Transportation.

Based on Source, the market was studied across Adipose Tissue-Derived Stem Cells, Bone Marrow-Derived Stem Cells, Dental Pulp-Derived Stem Cells, Human Embryo-Derived Stem Cells, and Placental Stem Cells.

Based on Type, the market was studied across Cord Blood and Cord Tissue.

Based on Application, the market was studied across Clinical Research and Personalized Banking.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Stem Cell Banking market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Stem Cell Banking Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Stem Cell Banking Market, including Amag Pharmaceuticals, Inc., Americord Registry LLC, BrainStorm Cell Therapeutics, Cellectis, China Cord Blood Corporation, Cord Blood America, Inc., Cordlife Group, CordVida, Cryo Stemcell Private Limited, Cryo-Cell International, Inc., Cryo-Save AG, Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V., Cryoviva, Global Cord Blood Corporation, Human Longevity, Inc, LifeCell International, Lifeforce Cryobank Sciences, Inc., PerkinElmer, Inc., Regrow Biosciences Pvt. Ltd, Smart Cells International Ltd., StemCyte, Inc., Takara Bio Europe AB, and Vita 34 International.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Stem Cell Banking Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Stem Cell Banking Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Stem Cell Banking Market?
4. What is the competitive strategic window for opportunities in the Global Stem Cell Banking Market?
5. What are the technology trends and regulatory frameworks in the Global Stem Cell Banking Market?
6. What is the market share of the leading vendors in the Global Stem Cell Banking Market?
7. What modes and strategic moves are considered suitable for entering the Global Stem Cell Banking Market?

Please Note: PDF & Excel + Online Access - 1 Year


Companies Mentioned

Amag Pharmaceuticals, Inc.
Americord Registry LLC
BrainStorm Cell Therapeutics
Cellectis
China Cord Blood Corporation
Cord Blood America, Inc.
Cordlife Group
CordVida
Cryo Stemcell Private Limited
Cryo-Cell International, Inc.
Cryo-Save AG
Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V.
Cryoviva
Global Cord Blood Corporation
Human Longevity, Inc
LifeCell International
Lifeforce Cryobank Sciences, Inc.
PerkinElmer, Inc.
Regrow Biosciences Pvt. Ltd
Smart Cells International Ltd.
StemCyte, Inc.
Takara Bio Europe AB
Vita 34 International

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising awareness of the therapeutic potential of stem cells
5.1.1.2. Technology development related to stem cell preservation, storage, and processing
5.1.1.3. Advance hematopoietic stem cell transplantation procedures
5.1.1.4. Investment friendly stem cell-based research
5.1.2. Restraints
5.1.2.1. Limited affordability of stem cell banking
5.1.2.2. Stringent regulatory frameworks
5.1.3. Opportunities
5.1.3.1. Increasing demand and potential from emerging countries
5.1.4. Challenges
5.1.4.1. Socio-ethical concerns related to embryonic stem cells
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Stem Cell Banking Market, by Service
6.1. Introduction
6.2. Analysis
6.3. Collection
6.4. Processing
6.5. Storage
6.6. Transportation
7. Stem Cell Banking Market, by Source
7.1. Introduction
7.2. Adipose Tissue-Derived Stem Cells
7.3. Bone Marrow-Derived Stem Cells
7.4. Dental Pulp-Derived Stem Cells
7.5. Human Embryo-Derived Stem Cells
7.6. Placental Stem Cells
8. Stem Cell Banking Market, by Type
8.1. Introduction
8.2. Cord Blood
8.3. Cord Tissue
9. Stem Cell Banking Market, by Application
9.1. Introduction
9.2. Clinical Research
9.3. Personalized Banking
10. Americas Stem Cell Banking Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Stem Cell Banking Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Stem Cell Banking Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Amag Pharmaceuticals, Inc.
14.2. Americord Registry LLC
14.3. BrainStorm Cell Therapeutics
14.4. Cellectis
14.5. China Cord Blood Corporation
14.6. Cord Blood America, Inc.
14.7. Cordlife Group
14.8. CordVida
14.9. Cryo Stemcell Private Limited
14.10. Cryo-Cell International, Inc.
14.11. Cryo-Save AG
14.12. Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V.
14.13. Cryoviva
14.14. Global Cord Blood Corporation
14.15. Human Longevity, Inc
14.16. LifeCell International
14.17. Lifeforce Cryobank Sciences, Inc.
14.18. PerkinElmer, Inc.
14.19. Regrow Biosciences Pvt. Ltd
14.20. Smart Cells International Ltd.
14.21. StemCyte, Inc.
14.22. Takara Bio Europe AB
14.23. Vita 34 International
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings